No Data
No Data
Piper Sandler Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $23
Express News | Cogent Biosciences Inc : Guggenheim Cuts Target Price to $17 From $20
J.P. Morgan Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $21
Cogent Biosciences Is Maintained at Buy by Needham
Needham Maintains Cogent Biosciences(COGT.US) With Buy Rating, Cuts Target Price to $15
Cogent Biosciences Analyst Ratings
No Data
No Data